{
    "medicine_id": "d94cb768b57f863c716d2dbf5ce69e9be45c4769",
    "platform_id": "DB04834",
    "metadata": {
        "name": "Raplon 100 mg 1 Injection",
        "composition": "100 mg 1 Rapacuronium",
        "clinical_particulars": {
            "therapeutic_indications": "Used in anaesthesia to aid and enable endotracheal intubation",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Rapacuronium is a rapidly acting non depolarizing neuromuscular blocker",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00921",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "Doxylamine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "Dronabinol may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "Droperidol may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Hydrocodone"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "Hydroxyzine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Rapacuronium may increase the sedative activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Minocycline may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "Nabilone may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Paraldehyde"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "Perampanel may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Rapacuronium may increase the sedative activities of Pramipexole"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "Rapacuronium may increase the sedative activities of Ropinirole"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Rapacuronium may increase the sedative activities of Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The risk or severity of adverse effects can be increased when Rufinamide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09072",
                        "description": "Sodium oxybate may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Suvorexant"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "Tapentadol may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Thalidomide"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Zolpidem"
                    },
                    {
                        "drugbank-id": "DB00314",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Capreomycin"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Doxycycline"
                    },
                    {
                        "drugbank-id": "DB00256",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Lymecycline"
                    },
                    {
                        "drugbank-id": "DB00452",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Framycetin"
                    },
                    {
                        "drugbank-id": "DB00453",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Clomocycline"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Quinine"
                    },
                    {
                        "drugbank-id": "DB00512",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Vancomycin"
                    },
                    {
                        "drugbank-id": "DB00560",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Tigecycline"
                    },
                    {
                        "drugbank-id": "DB00595",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Oxytetracycline"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB00618",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Demeclocycline"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Mecamylamine"
                    },
                    {
                        "drugbank-id": "DB00684",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Tobramycin"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Tetracycline"
                    },
                    {
                        "drugbank-id": "DB00798",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Gentamicin"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Etacrynic acid"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Quinidine"
                    },
                    {
                        "drugbank-id": "DB00931",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Metacycline"
                    },
                    {
                        "drugbank-id": "DB00955",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Netilmicin"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Neomycin"
                    },
                    {
                        "drugbank-id": "DB01082",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Streptomycin"
                    },
                    {
                        "drugbank-id": "DB01111",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Colistimethate"
                    },
                    {
                        "drugbank-id": "DB01172",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Kanamycin"
                    },
                    {
                        "drugbank-id": "DB01301",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Rolitetracycline"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01378",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium cation"
                    },
                    {
                        "drugbank-id": "DB01421",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Paromomycin"
                    },
                    {
                        "drugbank-id": "DB01627",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Lincomycin"
                    },
                    {
                        "drugbank-id": "DB03615",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Ribostamycin"
                    },
                    {
                        "drugbank-id": "DB04263",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Geneticin"
                    },
                    {
                        "drugbank-id": "DB04626",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Apramycin"
                    },
                    {
                        "drugbank-id": "DB04729",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Gentamicin C1a"
                    },
                    {
                        "drugbank-id": "DB04808",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Neamine"
                    },
                    {
                        "drugbank-id": "DB06696",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Arbekacin"
                    },
                    {
                        "drugbank-id": "DB06827",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Viomycin"
                    },
                    {
                        "drugbank-id": "DB08437",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Puromycin"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium hydroxide"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium trisilicate"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium chloride"
                    },
                    {
                        "drugbank-id": "DB09409",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium acetate tetrahydrate"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium carbonate"
                    },
                    {
                        "drugbank-id": "DB11110",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium citrate"
                    },
                    {
                        "drugbank-id": "DB11189",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium glycinate"
                    },
                    {
                        "drugbank-id": "DB11230",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium Aluminum Silicate"
                    },
                    {
                        "drugbank-id": "DB11512",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Dihydrostreptomycin"
                    },
                    {
                        "drugbank-id": "DB11520",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Hygromycin B"
                    },
                    {
                        "drugbank-id": "DB12604",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Sisomicin"
                    },
                    {
                        "drugbank-id": "DB12615",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Plazomicin"
                    },
                    {
                        "drugbank-id": "DB13249",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13264",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Penimepicycline"
                    },
                    {
                        "drugbank-id": "DB13359",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium aspartate"
                    },
                    {
                        "drugbank-id": "DB13540",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Isepamicin"
                    },
                    {
                        "drugbank-id": "DB13749",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium gluconate"
                    },
                    {
                        "drugbank-id": "DB13786",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium orotate"
                    },
                    {
                        "drugbank-id": "DB13862",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium phosphate"
                    },
                    {
                        "drugbank-id": "DB13996",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium acetate"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Procainamide"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Dantrolene"
                    },
                    {
                        "drugbank-id": "DB00319",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Piperacillin"
                    },
                    {
                        "drugbank-id": "DB14077",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium stearate"
                    },
                    {
                        "drugbank-id": "DB00803",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Colistin"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Aclidinium"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "Mianserin may increase the anticholinergic activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The risk or severity of urinary retention can be increased when Rapacuronium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00761",
                        "description": "The risk or severity of gastrointestinal ulceration can be increased when Rapacuronium is combined with Potassium chloride"
                    },
                    {
                        "drugbank-id": "DB01278",
                        "description": "The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09527",
                        "description": "The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Tiotropium"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The risk or severity of hyperthermia and oligohydrosis can be increased when Rapacuronium is combined with Topiramate"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Umeclidinium"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of adverse effects can be increased when Methadone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Glycopyrronium"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Botulinum toxin type A"
                    },
                    {
                        "drugbank-id": "DB00040",
                        "description": "Rapacuronium may increase the gastrointestinal motility reducing activities of Glucagon"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "Rapacuronium may increase the anticholinergic activities of Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Botulinum Toxin Type B"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The risk or severity of constipation can be increased when Rapacuronium is combined with Eluxadoline"
                    },
                    {
                        "drugbank-id": "DB09290",
                        "description": "The risk or severity of constipation can be increased when Rapacuronium is combined with Ramosetron"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Ethanol"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Azelastine"
                    },
                    {
                        "drugbank-id": "DB00484",
                        "description": "Brimonidine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Trazodone"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Sertraline"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Sibutramine"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Indalpine"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB01459",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Bezitramide"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The risk or severity of adverse effects can be increased when Desomorphine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The risk or severity of adverse effects can be increased when Nicomorphine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of adverse effects can be increased when Morphine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The risk or severity of adverse effects can be increased when Codeine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The risk or severity of adverse effects can be increased when Hydromorphone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The risk or severity of adverse effects can be increased when Meperidine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The risk or severity of adverse effects can be increased when Oxycodone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The risk or severity of adverse effects can be increased when Butorphanol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The risk or severity of adverse effects can be increased when Pentazocine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of adverse effects can be increased when Sufentanil is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of adverse effects can be increased when Alfentanil is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of adverse effects can be increased when Fentanyl is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The risk or severity of adverse effects can be increased when Levorphanol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of adverse effects can be increased when Remifentanil is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The risk or severity of adverse effects can be increased when Oxymorphone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The risk or severity of adverse effects can be increased when Dezocine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The risk or severity of adverse effects can be increased when Diamorphine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The risk or severity of adverse effects can be increased when Etorphine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The risk or severity of adverse effects can be increased when Dextromoramide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The risk or severity of adverse effects can be increased when Carfentanil is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The risk or severity of adverse effects can be increased when Dihydromorphine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Ketobemidone"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with DPDPE"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Lofentanil"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Opium"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Normethadone"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Piritramide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Tilidine"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB15465",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Benzhydrocodone"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Rapacuronium is combined with Digoxin"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Rapacuronium is combined with Acetyldigitoxin"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Rapacuronium is combined with Deslanoside"
                    },
                    {
                        "drugbank-id": "DB01092",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Rapacuronium is combined with Ouabain"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Rapacuronium is combined with Digitoxin"
                    },
                    {
                        "drugbank-id": "DB12843",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Rapacuronium is combined with Oleandrin"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Rapacuronium is combined with Cymarin"
                    },
                    {
                        "drugbank-id": "DB13307",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Rapacuronium is combined with Proscillaridin"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Rapacuronium is combined with Metildigoxin"
                    },
                    {
                        "drugbank-id": "DB13467",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Rapacuronium is combined with Lanatoside C"
                    },
                    {
                        "drugbank-id": "DB13537",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Rapacuronium is combined with Gitoformate"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Rapacuronium is combined with Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB13756",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Rapacuronium is combined with Peruvoside"
                    },
                    {
                        "drugbank-id": "DB00809",
                        "description": "The risk or severity of adverse effects can be increased when Tropicamide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of adverse effects can be increased when Amantadine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00979",
                        "description": "The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "The risk or severity of adverse effects can be increased when Pentolinium is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "The risk or severity of adverse effects can be increased when Trimethaphan is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01161",
                        "description": "The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The risk or severity of adverse effects can be increased when Fenoterol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01496",
                        "description": "The risk or severity of adverse effects can be increased when Dihydro 2 thioxo 5 5 2 trifluoromethyl phenyl 2 furanyl methyl 4 6 1H 5H pyrimidinedione is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11181",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Homatropine"
                    },
                    {
                        "drugbank-id": "DB09271",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Cimetropium"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The serum concentration of Methyclothiazide can be increased when it is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "The serum concentration of Chlorthalidone can be increased when it is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The serum concentration of Bendroflumethiazide can be increased when it is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "The serum concentration of Metolazone can be increased when it is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The serum concentration of Benzthiazide can be increased when it is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The serum concentration of Hydroflumethiazide can be increased when it is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The serum concentration of Indapamide can be increased when it is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The serum concentration of Chlorothiazide can be increased when it is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The serum concentration of Trichlormethiazide can be increased when it is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The serum concentration of Polythiazide can be increased when it is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "The serum concentration of Quinethazone can be increased when it is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The serum concentration of Cyclopenthiazide can be increased when it is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "The serum concentration of Epitizide can be increased when it is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Ipratropium"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The risk or severity of adverse effects can be increased when Ketorolac is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01046",
                        "description": "The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The therapeutic efficacy of Tegaserod can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01593",
                        "description": "The therapeutic efficacy of Zinc can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "The therapeutic efficacy of Sorbitol can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04816",
                        "description": "The therapeutic efficacy of Dantron can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04823",
                        "description": "The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04824",
                        "description": "The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The therapeutic efficacy of Prucalopride can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB07715",
                        "description": "The therapeutic efficacy of Emodin can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB08890",
                        "description": "The therapeutic efficacy of Linaclotide can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09020",
                        "description": "The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09219",
                        "description": "The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09287",
                        "description": "The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09311",
                        "description": "The therapeutic efficacy of Polycarbophil can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09413",
                        "description": "The therapeutic efficacy of Monopotassium phosphate can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09414",
                        "description": "The therapeutic efficacy of Dipotassium phosphate can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09449",
                        "description": "The therapeutic efficacy of Sodium phosphate monobasic can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09462",
                        "description": "The therapeutic efficacy of Glycerin can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09484",
                        "description": "The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11057",
                        "description": "The therapeutic efficacy of Mineral oil can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11059",
                        "description": "The therapeutic efficacy of Carboxymethylcellulose can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11089",
                        "description": "The therapeutic efficacy of Docusate can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11097",
                        "description": "The therapeutic efficacy of Plantago seed can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11113",
                        "description": "The therapeutic efficacy of Castor oil can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11228",
                        "description": "The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11365",
                        "description": "The therapeutic efficacy of Sennosides can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB12942",
                        "description": "The therapeutic efficacy of Lactitol can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13170",
                        "description": "The therapeutic efficacy of Plecanatide can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13526",
                        "description": "The therapeutic efficacy of Pentaerithrityl can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13707",
                        "description": "The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14232",
                        "description": "The therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14482",
                        "description": "The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "The therapeutic efficacy of Potassium sulfate can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14502",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14503",
                        "description": "The therapeutic efficacy of Sodium phosphate monobasic unspecified form can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14504",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic unspecified form can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14585",
                        "description": "The therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14627",
                        "description": "The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14684",
                        "description": "The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14963",
                        "description": "The therapeutic efficacy of Konjac mannan can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB15477",
                        "description": "The therapeutic efficacy of Alloin can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB15478",
                        "description": "The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11622",
                        "description": "The therapeutic efficacy of Dehydrocholic acid can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14516",
                        "description": "The therapeutic efficacy of Sodium cation can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14546",
                        "description": "The therapeutic efficacy of Sulfate ion can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "Profenamine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "Chlorpromazine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "Gallamine triethiodide may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "Triflupromazine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "Procaine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "Minaprine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "Hexafluronium may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "Tubocurarine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "Ketamine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "Decamethonium may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "Pancuronium may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "Pipecuronium may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "Venlafaxine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "Amitriptyline may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "Cyproheptadine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "Imipramine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "Dextromethorphan may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "Nortriptyline may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "Amoxapine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00662",
                        "description": "Trimethobenzamide may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "Propiomazine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "Diethylpropion may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "Levocabastine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Doxepin may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "Desipramine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Trospium"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Oxyphenonium"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Benzatropine"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Metixene"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Buclizine"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Trihexyphenidyl"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Oxyphencyclimine"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Procyclidine"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Methscopolamine bromide"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Darifenacin"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Tridihexethyl"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Anisotropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Atropine"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Pirenzepine"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Homatropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Benzquinamide"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Propantheline"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Dicyclomine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Biperiden"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Cocaine"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Methantheline"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Cycrimine"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Tolterodine"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Flavoxate"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Diphenidol"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Solifenacin"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Isopropamide"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Mepenzolate"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Pizotifen"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Fesoterodine"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Hexocyclium"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Dimetindene"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Dexetimide"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Dosulepin"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Imidafenacin"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Revefenacin"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Propiverine"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Batefenterol"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Tropatepine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Prifinium"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Benzilone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Difemerine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Phenglutarimide"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Mazaticol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Etybenzatropine"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Bevonium"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Rociverine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Bornaprine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Etanautine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Penthienate"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Timepidium"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB12327",
                        "description": "Salvinorin A may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14718",
                        "description": "Pyrazolam may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "Gabapentin may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Desloratadine"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "Lemborexant may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Chlorphenoxamine"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Zopiclone"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "Isradipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "Diltiazem may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "Trimethadione may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "Amlodipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "Nimodipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Nisoldipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "Lercanidipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "Lamotrigine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "Cinnarizine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "Ethosuximide may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "Nicardipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "Verapamil may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "Loperamide may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "Zonisamide may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "Felodipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "Nitrendipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "Perhexiline may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "Nifedipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "Amiodarone may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "Carvedilol may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "Bepridil may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "Mibefradil may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "Nimesulide may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "Prenylamine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04838",
                        "description": "Cyclandelate may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "Flunarizine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "Fluspirilene may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "Clevidipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "Methsuximide may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB05885",
                        "description": "Seletracetam may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "Nylidrin may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "Ziconotide may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "Dotarizine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "Xylometazoline may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "Nilvadipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "Tranilast may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB08162",
                        "description": "Fasudil may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "Agmatine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "Fendiline may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "Eperisone may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Trimebutine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "Pinaverium may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "Tolfenamic acid may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "Barnidipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "Aranidipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09230",
                        "description": "Azelnidipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "Benidipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09232",
                        "description": "Cilnidipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09234",
                        "description": "Darodipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Efonidipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "Lacidipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "Manidipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "Niguldipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09240",
                        "description": "Niludipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11960",
                        "description": "Carboxyamidotriazole may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "Naftopidil may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "Tetrahydropalmatine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "Vinpocetine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "Gallopamil may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "Bencyclane may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "Otilonium may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "Terodiline may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "Lidoflazine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "Penfluridol may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13835",
                        "description": "Caroverine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13961",
                        "description": "Fish oil may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "Dexverapamil may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14064",
                        "description": "Emopamil may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14065",
                        "description": "Lomerizine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "Tetrandrine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "Dexniguldipine may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "The risk or severity of adverse effects can be increased when Levetiracetam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00150",
                        "description": "The risk or severity of adverse effects can be increased when Tryptophan is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of adverse effects can be increased when Amphetamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The risk or severity of adverse effects can be increased when Lorazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00189",
                        "description": "The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of adverse effects can be increased when Succinylcholine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The risk or severity of adverse effects can be increased when Reserpine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The risk or severity of adverse effects can be increased when Eletriptan is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "The risk or severity of adverse effects can be increased when Temazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The risk or severity of adverse effects can be increased when Reboxetine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The risk or severity of adverse effects can be increased when Butabarbital is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The risk or severity of adverse effects can be increased when Butalbital is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The risk or severity of adverse effects can be increased when Methysergide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The risk or severity of adverse effects can be increased when Cabergoline is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of adverse effects can be increased when Clemastine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of adverse effects can be increased when Atomoxetine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The risk or severity of adverse effects can be increased when Etomidate is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "The risk or severity of adverse effects can be increased when Talbutal is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The risk or severity of adverse effects can be increased when Pentobarbital is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of adverse effects can be increased when Valproic acid is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "The risk or severity of adverse effects can be increased when Tolcapone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of adverse effects can be increased when Olanzapine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of adverse effects can be increased when Cetirizine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of adverse effects can be increased when Protriptyline is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The risk or severity of adverse effects can be increased when Clobazam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of adverse effects can be increased when Clozapine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00371",
                        "description": "The risk or severity of adverse effects can be increased when Meprobamate is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The risk or severity of adverse effects can be increased when Palonosetron is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The risk or severity of adverse effects can be increased when Alprazolam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The risk or severity of adverse effects can be increased when Loxapine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The risk or severity of adverse effects can be increased when Remoxipride is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The risk or severity of adverse effects can be increased when Secobarbital is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of adverse effects can be increased when Promazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00423",
                        "description": "The risk or severity of adverse effects can be increased when Methocarbamol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of adverse effects can be increased when Triprolidine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The risk or severity of adverse effects can be increased when Metharbital is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The risk or severity of adverse effects can be increased when Methohexital is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00475",
                        "description": "The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The risk or severity of adverse effects can be increased when Entacapone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The risk or severity of adverse effects can be increased when Mephenytoin is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "The risk or severity of adverse effects can be increased when Adinazolam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The risk or severity of adverse effects can be increased when Carbamazepine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "The risk or severity of adverse effects can be increased when Cisatracurium is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The risk or severity of adverse effects can be increased when Fenfluramine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00579",
                        "description": "The risk or severity of adverse effects can be increased when Mazindol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The risk or severity of adverse effects can be increased when Lisuride is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The risk or severity of adverse effects can be increased when Thiopental is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of adverse effects can be increased when Linezolid is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of adverse effects can be increased when Cisapride is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of adverse effects can be increased when Furazolidone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The risk or severity of adverse effects can be increased when Paramethadione is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The risk or severity of adverse effects can be increased when Fluphenazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of adverse effects can be increased when Efavirenz is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00645",
                        "description": "The risk or severity of adverse effects can be increased when Dyclonine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "The risk or severity of adverse effects can be increased when Metaxalone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The risk or severity of adverse effects can be increased when Sumatriptan is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of adverse effects can be increased when Thioridazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of adverse effects can be increased when Moricizine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The risk or severity of adverse effects can be increased when Midazolam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "The risk or severity of adverse effects can be increased when Flurazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The risk or severity of adverse effects can be increased when Ergotamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of adverse effects can be increased when Tizanidine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of adverse effects can be increased when Apomorphine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of adverse effects can be increased when Trimipramine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of adverse effects can be increased when Rocuronium is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of adverse effects can be increased when Risperidone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The risk or severity of adverse effects can be increased when Meclizine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The risk or severity of adverse effects can be increased when Riluzole is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "The risk or severity of adverse effects can be increased when Scopolamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of adverse effects can be increased when Isoflurane is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The risk or severity of adverse effects can be increased when Ethotoin is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of adverse effects can be increased when Dolasetron is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The risk or severity of adverse effects can be increased when Clidinium is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of adverse effects can be increased when Phenelzine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The risk or severity of adverse effects can be increased when Primidone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00801",
                        "description": "The risk or severity of adverse effects can be increased when Halazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of adverse effects can be increased when Propofol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The risk or severity of adverse effects can be increased when Acetazolamide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The risk or severity of adverse effects can be increased when Diazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "The risk or severity of adverse effects can be increased when Phensuximide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of adverse effects can be increased when Brompheniramine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The risk or severity of adverse effects can be increased when Progabide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "The risk or severity of adverse effects can be increased when Oxazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The risk or severity of adverse effects can be increased when Perphenazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The risk or severity of adverse effects can be increased when Benzphetamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The risk or severity of adverse effects can be increased when Alprenolol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of adverse effects can be increased when Flupentixol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of adverse effects can be increased when Granisetron is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of adverse effects can be increased when Triazolam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "The risk or severity of adverse effects can be increased when Tiagabine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The risk or severity of adverse effects can be increased when Almotriptan is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of adverse effects can be increased when Felbamate is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of adverse effects can be increased when Naratriptan is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "The risk or severity of adverse effects can be increased when Rizatriptan is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The risk or severity of adverse effects can be increased when Pindolol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The risk or severity of adverse effects can be increased when Zaleplon is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00969",
                        "description": "The risk or severity of adverse effects can be increased when Alosetron is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "The risk or severity of adverse effects can be increased when Ramelteon is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The risk or severity of adverse effects can be increased when Frovatriptan is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The risk or severity of adverse effects can be increased when Guanfacine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of adverse effects can be increased when Selegiline is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The risk or severity of adverse effects can be increased when Acetophenazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01065",
                        "description": "The risk or severity of adverse effects can be increased when Melatonin is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "The risk or severity of adverse effects can be increased when Clonazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of adverse effects can be increased when Promethazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "The risk or severity of adverse effects can be increased when Vigabatrin is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of adverse effects can be increased when Pimozide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01107",
                        "description": "The risk or severity of adverse effects can be increased when Methyprylon is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "The risk or severity of adverse effects can be increased when Phenacemide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "The risk or severity of adverse effects can be increased when Doxacurium is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The risk or severity of adverse effects can be increased when Thiamylal is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The risk or severity of adverse effects can be increased when Bupropion is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of adverse effects can be increased when Halothane is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Procarbazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of adverse effects can be increased when Moclobemide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The risk or severity of adverse effects can be increased when Phenobarbital is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of adverse effects can be increased when Cyclizine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01178",
                        "description": "The risk or severity of adverse effects can be increased when Chlormezanone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The risk or severity of adverse effects can be increased when Pergolide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of adverse effects can be increased when Desflurane is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The risk or severity of adverse effects can be increased when Bromocriptine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The risk or severity of adverse effects can be increased when Estazolam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of adverse effects can be increased when Quetiapine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The risk or severity of adverse effects can be increased when Mivacurium is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of adverse effects can be increased when Sevoflurane is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of adverse effects can be increased when Aripiprazole is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of adverse effects can be increased when Clomipramine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of adverse effects can be increased when Alimemazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The risk or severity of adverse effects can be increased when Ergometrine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of adverse effects can be increased when Paliperidone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The risk or severity of adverse effects can be increased when St John s Wort is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The risk or severity of adverse effects can be increased when Metocurine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "The risk or severity of adverse effects can be increased when Vecuronium is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The risk or severity of adverse effects can be increased when Amobarbital is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The risk or severity of adverse effects can be increased when Aprobarbital is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "The risk or severity of adverse effects can be increased when Butobarbital is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "The risk or severity of adverse effects can be increased when Heptabarbital is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The risk or severity of adverse effects can be increased when Hexobarbital is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The risk or severity of adverse effects can be increased when Penbutolol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of adverse effects can be increased when Rasagiline is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of adverse effects can be increased when Yohimbine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01437",
                        "description": "The risk or severity of adverse effects can be increased when Glutethimide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01440",
                        "description": "The risk or severity of adverse effects can be increased when gamma Hydroxybutyric acid is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The risk or severity of adverse effects can be increased when MMDA is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01445",
                        "description": "The risk or severity of adverse effects can be increased when Bufotenine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The risk or severity of adverse effects can be increased when Midomafetamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01463",
                        "description": "The risk or severity of adverse effects can be increased when Fencamfamin is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The risk or severity of adverse effects can be increased when 4 Methoxyamphetamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The risk or severity of adverse effects can be increased when Barbital is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The risk or severity of adverse effects can be increased when 4 Bromo 2 5 dimethoxyamphetamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01488",
                        "description": "The risk or severity of adverse effects can be increased when Dimethyltryptamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01489",
                        "description": "The risk or severity of adverse effects can be increased when Camazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01495",
                        "description": "The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01501",
                        "description": "The risk or severity of adverse effects can be increased when Difenoxin is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The risk or severity of adverse effects can be increased when Tenamfetamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The risk or severity of adverse effects can be increased when Delorazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01534",
                        "description": "The risk or severity of adverse effects can be increased when Chlorhexadol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01545",
                        "description": "The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01547",
                        "description": "The risk or severity of adverse effects can be increased when Drotebanol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01553",
                        "description": "The risk or severity of adverse effects can be increased when Cloxazolam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "The risk or severity of adverse effects can be increased when Bromazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01559",
                        "description": "The risk or severity of adverse effects can be increased when Clotiazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01560",
                        "description": "The risk or severity of adverse effects can be increased when Cathinone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01567",
                        "description": "The risk or severity of adverse effects can be increased when Fludiazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The risk or severity of adverse effects can be increased when Metamfetamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of adverse effects can be increased when Oxprenolol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The risk or severity of adverse effects can be increased when Ketazolam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01588",
                        "description": "The risk or severity of adverse effects can be increased when Prazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01589",
                        "description": "The risk or severity of adverse effects can be increased when Quazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01594",
                        "description": "The risk or severity of adverse effects can be increased when Cinolazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The risk or severity of adverse effects can be increased when Nitrazepam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The risk or severity of adverse effects can be increased when Periciazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of adverse effects can be increased when Acepromazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of adverse effects can be increased when Aceprometazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01616",
                        "description": "The risk or severity of adverse effects can be increased when Alverine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "The risk or severity of adverse effects can be increased when Molindone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The risk or severity of adverse effects can be increased when Pipotiazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The risk or severity of adverse effects can be increased when Thioproperazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of adverse effects can be increased when Thiothixene is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of adverse effects can be increased when Pargyline is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01954",
                        "description": "The risk or severity of adverse effects can be increased when Rolipram is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The risk or severity of adverse effects can be increased when 7 Nitroindazole is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB02234",
                        "description": "The risk or severity of adverse effects can be increased when S Ethylisothiourea is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB02852",
                        "description": "The risk or severity of adverse effects can be increased when Domoic Acid is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB02959",
                        "description": "The risk or severity of adverse effects can be increased when Oxitriptan is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB03575",
                        "description": "The risk or severity of adverse effects can be increased when Phencyclidine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of adverse effects can be increased when Clorgiline is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "The risk or severity of adverse effects can be increased when Valpromide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04325",
                        "description": "The risk or severity of adverse effects can be increased when Phenethylamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04599",
                        "description": "The risk or severity of adverse effects can be increased when Aniracetam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of adverse effects can be increased when Iproniazid is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04819",
                        "description": "The risk or severity of adverse effects can be increased when Methapyrilene is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of adverse effects can be increased when Nialamide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04821",
                        "description": "The risk or severity of adverse effects can be increased when Nomifensine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04827",
                        "description": "The risk or severity of adverse effects can be increased when Urethane is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The risk or severity of adverse effects can be increased when Lysergic acid diethylamide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04833",
                        "description": "The risk or severity of adverse effects can be increased when Methaqualone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Amineptine"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Lorcaserin"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Osanetant"
                    },
                    {
                        "drugbank-id": "DB04885",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Cilansetron"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Bifeprunox"
                    },
                    {
                        "drugbank-id": "DB04903",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Pagoclone"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB04917",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Renzapride"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Ezogabine"
                    },
                    {
                        "drugbank-id": "DB05227",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with APD791"
                    },
                    {
                        "drugbank-id": "DB05232",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Tetrodotoxin"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Pimavanserin"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Brivaracetam"
                    },
                    {
                        "drugbank-id": "DB05542",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Naronapride"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Naluzotan"
                    },
                    {
                        "drugbank-id": "DB05607",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with PRX 08066"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with BL 1020"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Gantacurium"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Lumateperone"
                    },
                    {
                        "drugbank-id": "DB06109",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with YKP 1358"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Sertindole"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Lacosamide"
                    },
                    {
                        "drugbank-id": "DB06264",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Tolperisone"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Levocetirizine"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Amisulpride"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Remacemide"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Clomethiazole"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Deramciclane"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Tramiprosate"
                    },
                    {
                        "drugbank-id": "DB06529",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Ocinaplon"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Gaboxadol"
                    },
                    {
                        "drugbank-id": "DB06579",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Adipiplon"
                    },
                    {
                        "drugbank-id": "DB06582",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Dextofisopam"
                    },
                    {
                        "drugbank-id": "DB06594",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Agomelatine"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB06660",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Saredutant"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Esmirtazapine"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Vilazodone"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Nitrous oxide"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Dexmethylphenidate"
                    },
                    {
                        "drugbank-id": "DB06716",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Fospropofol"
                    },
                    {
                        "drugbank-id": "DB06753",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Triclofos"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Benzyl alcohol"
                    },
                    {
                        "drugbank-id": "DB06797",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Mebutamate"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Wortmannin"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Sulthiame"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Cinitapride"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Tofisopam"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08839",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Serotonin"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Gabapentin enacarbil"
                    },
                    {
                        "drugbank-id": "DB08892",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Arbaclofen Placarbil"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Perospirone"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Amperozide"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Ifenprodil"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB08986",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Etifoxine"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Dimetacrine"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Cyamemazine"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Barbexaclone"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Beclamide"
                    },
                    {
                        "drugbank-id": "DB09014",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Captodiame"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09017",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Brotizolam"
                    },
                    {
                        "drugbank-id": "DB09021",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Benzoctamine"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Benactyzine"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Tasimelteon"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Eslicarbazepine acetate"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Etizolam"
                    },
                    {
                        "drugbank-id": "DB09184",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Edivoxetine"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Viloxazine"
                    },
                    {
                        "drugbank-id": "DB09186",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Nisoxetine"
                    },
                    {
                        "drugbank-id": "DB09187",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Lortalamine"
                    },
                    {
                        "drugbank-id": "DB09190",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Talopram"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Etoperidone"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Blonanserin"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Zotepine"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Brilaroxazine"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Hydracarbazine"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Pirlindole"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Toloxatone"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Benmoxin"
                    },
                    {
                        "drugbank-id": "DB09247",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Iproclozide"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Mebanazine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Octamoxin"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Pheniprazine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Phenoxypropazine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Pivhydrazine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Safrazine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Caroxazone"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Oxaprotiline"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Pyrantel"
                    },
                    {
                        "drugbank-id": "DB11371",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Alfaxalone"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Azaperone"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Doramectin"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Xylazine"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Propiopromazine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Romifidine"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Tiletamine"
                    },
                    {
                        "drugbank-id": "DB11552",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Tricaine"
                    },
                    {
                        "drugbank-id": "DB11555",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Zolazepam"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Detomidine"
                    },
                    {
                        "drugbank-id": "DB11582",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Thiocolchicoside"
                    },
                    {
                        "drugbank-id": "DB11664",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Psilocybin"
                    },
                    {
                        "drugbank-id": "DB11675",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Mosapride"
                    },
                    {
                        "drugbank-id": "DB11686",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Iferanserin"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Tropisetron"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Brexanolone"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Etiracetam"
                    },
                    {
                        "drugbank-id": "DB11889",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Lanicemine"
                    },
                    {
                        "drugbank-id": "DB11957",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Idalopirdine"
                    },
                    {
                        "drugbank-id": "DB12071",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Vabicaserin"
                    },
                    {
                        "drugbank-id": "DB12105",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Imagabalin"
                    },
                    {
                        "drugbank-id": "DB12110",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with m Chlorophenylpiperazine"
                    },
                    {
                        "drugbank-id": "DB12111",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with MK 212"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Sarpogrelate"
                    },
                    {
                        "drugbank-id": "DB12177",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Eplivanserin"
                    },
                    {
                        "drugbank-id": "DB12184",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Gepirone"
                    },
                    {
                        "drugbank-id": "DB12229",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Cerlapirdine"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Ecopipam"
                    },
                    {
                        "drugbank-id": "DB12308",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Eltanolone"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Carisbamate"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Piclozotan"
                    },
                    {
                        "drugbank-id": "DB12395",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Esreboxetine"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Bromperidol"
                    },
                    {
                        "drugbank-id": "DB12427",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Orvepitant"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Raclopride"
                    },
                    {
                        "drugbank-id": "DB12537",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Benzodiazepine"
                    },
                    {
                        "drugbank-id": "DB12576",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with AZD 3043"
                    },
                    {
                        "drugbank-id": "DB12590",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Indiplon"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Urapidil"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Perazine"
                    },
                    {
                        "drugbank-id": "DB12725",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with TD 8954"
                    },
                    {
                        "drugbank-id": "DB12833",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Tandospirone"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Benperidol"
                    },
                    {
                        "drugbank-id": "DB12883",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Eltoprazine"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Opipramol"
                    },
                    {
                        "drugbank-id": "DB12951",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Pivagabine"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Prothipendyl"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Neosaxitoxin"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Tiapride"
                    },
                    {
                        "drugbank-id": "DB13082",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Nefiracetam"
                    },
                    {
                        "drugbank-id": "DB13099",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Valnoctamide"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Amitriptylinoxide"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Butaperazine"
                    },
                    {
                        "drugbank-id": "DB13219",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Medifoxamine"
                    },
                    {
                        "drugbank-id": "DB13221",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Apronalide"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Dibenzepin"
                    },
                    {
                        "drugbank-id": "DB13234",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Propanidid"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Quinupramine"
                    },
                    {
                        "drugbank-id": "DB13253",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Proxibarbal"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Clothiapine"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Atracurium"
                    },
                    {
                        "drugbank-id": "DB13303",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Febarbamate"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Trichloroethylene"
                    },
                    {
                        "drugbank-id": "DB13324",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Tetrazepam"
                    },
                    {
                        "drugbank-id": "DB13331",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Pyrithyldione"
                    },
                    {
                        "drugbank-id": "DB13335",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Pinazepam"
                    },
                    {
                        "drugbank-id": "DB13352",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Deanol"
                    },
                    {
                        "drugbank-id": "DB13354",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Phenprobamate"
                    },
                    {
                        "drugbank-id": "DB13357",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Styramate"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Pheneturide"
                    },
                    {
                        "drugbank-id": "DB13370",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Bromisoval"
                    },
                    {
                        "drugbank-id": "DB13377",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Vinbarbital"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Chlorproethazine"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Melitracen"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Neocitrullamon"
                    },
                    {
                        "drugbank-id": "DB13402",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Acetylglycinamide chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Oxypertine"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13414",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Fenyramidol"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Thiazinam"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Medazepam"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Phenibut"
                    },
                    {
                        "drugbank-id": "DB13457",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Oxaflozane"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Iprindole"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Emepronium"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Metergoline"
                    },
                    {
                        "drugbank-id": "DB13522",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Mebicar"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Veralipride"
                    },
                    {
                        "drugbank-id": "DB13534",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Gedocarnil"
                    },
                    {
                        "drugbank-id": "DB13541",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Iprazochrome"
                    },
                    {
                        "drugbank-id": "DB13550",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Bifemelane"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Trifluperidol"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Moperone"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Thiopropazate"
                    },
                    {
                        "drugbank-id": "DB13572",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Emylcamate"
                    },
                    {
                        "drugbank-id": "DB13577",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Allobarbital"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Gallamine"
                    },
                    {
                        "drugbank-id": "DB13588",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Naftidrofuryl"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB13601",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Oxiracetam"
                    },
                    {
                        "drugbank-id": "DB13623",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Fabomotizole"
                    },
                    {
                        "drugbank-id": "DB13642",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Pridinol"
                    },
                    {
                        "drugbank-id": "DB13643",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Loprazolam"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Alcuronium"
                    },
                    {
                        "drugbank-id": "DB13662",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Hexapropymate"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Fluanisone"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Mosapramine"
                    },
                    {
                        "drugbank-id": "DB13687",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Niaprazine"
                    },
                    {
                        "drugbank-id": "DB13690",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Vinyl ether"
                    },
                    {
                        "drugbank-id": "DB13733",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Methylpentynol"
                    },
                    {
                        "drugbank-id": "DB13737",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Cyclobarbital"
                    },
                    {
                        "drugbank-id": "DB13745",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Fazadinium bromide"
                    },
                    {
                        "drugbank-id": "DB13754",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Mephenoxalone"
                    },
                    {
                        "drugbank-id": "DB13770",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Vinylbital"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Ethadione"
                    },
                    {
                        "drugbank-id": "DB13805",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Reposal"
                    },
                    {
                        "drugbank-id": "DB13817",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Carbromal"
                    },
                    {
                        "drugbank-id": "DB13837",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Doxefazepam"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Clopenthixol"
                    },
                    {
                        "drugbank-id": "DB13872",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Lormetazepam"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Harmaline"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Brofaromine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB13948",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with N 2 hydroxybenzyl 2 5 dimethoxy 4 cyanophenylethylamine"
                    },
                    {
                        "drugbank-id": "DB13984",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Cyclopropane"
                    },
                    {
                        "drugbank-id": "DB13993",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with MRK 409"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB14028",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Nordazepam"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Cannabidivarin"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Lithium carbonate"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Eslicarbazepine"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB14672",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Oxazepam acetate"
                    },
                    {
                        "drugbank-id": "DB14715",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Cinazepam"
                    },
                    {
                        "drugbank-id": "DB14719",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Bentazepam"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with JNJ 26489112"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "Torasemide may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Furosemide may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "Bumetanide may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "Piretanide may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "Azosemide may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The therapeutic efficacy of Rapacuronium can be decreased when used in combination with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The therapeutic efficacy of Rapacuronium can be decreased when used in combination with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Flunisolide"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Beclomethasone dipropionate"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Betamethasone"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Fluticasone propionate"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Fluocinolone acetonide"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Triamcinolone"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Prednisone"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Fludrocortisone"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Hydrocortisone"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Prednisolone"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Methylprednisolone"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Trilostane"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Budesonide"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Corticotropin"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Cortisone acetate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Paramethasone"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Ciclesonide"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Aldosterone"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Fluprednidene"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Tixocortol"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Fluprednisolone"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Meprednisone"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Dexamethasone isonicotinate"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Melengestrol"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Deflazacort"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Cortivazol"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Prednylidene"
                    },
                    {
                        "drugbank-id": "DB13223",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Fluocortin"
                    },
                    {
                        "drugbank-id": "DB13491",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Fluperolone"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Cloprednol"
                    },
                    {
                        "drugbank-id": "DB13856",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Fluclorolone"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Fluticasone"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Mometasone furoate"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Hydrocortisone acetate"
                    },
                    {
                        "drugbank-id": "DB14541",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Hydrocortisone cypionate"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Hydrocortisone succinate"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Prednisolone phosphate"
                    },
                    {
                        "drugbank-id": "DB14633",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Prednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14644",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Methylprednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Prednisone acetate"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Clocortolone acetate"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Melengestrol acetate"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Betamethasone phosphate"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Cortisone"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Clobetasol propionate"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Fluocinonide"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Hydrocortisone butyrate"
                    },
                    {
                        "drugbank-id": "DB00547",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Desoximetasone"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Mometasone"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Fluocortolone"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Clobetasol"
                    },
                    {
                        "drugbank-id": "DB15566",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Prednisolone acetate"
                    },
                    {
                        "drugbank-id": "DB00324",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Fluorometholone"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Difluocortolone"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "Pegvisomant may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "Mefloquine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00382",
                        "description": "Tacrine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "Cisplatin may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00527",
                        "description": "Cinchocaine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00545",
                        "description": "Pyridostigmine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00585",
                        "description": "Nizatidine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "Galantamine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00677",
                        "description": "Isoflurophate may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00711",
                        "description": "Diethylcarbamazine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "Terbutaline may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "Mechlorethamine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00944",
                        "description": "Demecarium may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00981",
                        "description": "Physostigmine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00989",
                        "description": "Rivastigmine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01010",
                        "description": "Edrophonium may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Memantine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01122",
                        "description": "Ambenonium may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01381",
                        "description": "Ginkgo biloba may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01400",
                        "description": "Neostigmine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "Bambuterol may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB02365",
                        "description": "1 10 Phenanthroline may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "Thiotepa may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04864",
                        "description": "Huperzine A may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04892",
                        "description": "Phenserine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB05386",
                        "description": "Regramostim may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB06692",
                        "description": "Aprotinin may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB06756",
                        "description": "Glycine betaine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB06774",
                        "description": "Capsaicin may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "Coumaphos may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "Dichlorvos may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "Fenthion may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11473",
                        "description": "Metrifonate may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB12482",
                        "description": "Acotiamide may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13058",
                        "description": "Methanesulfonyl Fluoride may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13495",
                        "description": "Paraoxon may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13503",
                        "description": "Tyrothricin may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13668",
                        "description": "Ipidacrine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13694",
                        "description": "Distigmine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14031",
                        "description": "Tretamine may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB15317",
                        "description": "Posiphen may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB02845",
                        "description": "Methylphosphinic Acid may decrease the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13453",
                        "description": "Xenon may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Pregabalin"
                    },
                    {
                        "drugbank-id": "DB09532",
                        "description": "The therapeutic efficacy of Secretin human can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of adverse effects can be increased when Rimonabant is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB06624",
                        "description": "The risk or severity of adverse effects can be increased when Taranabant is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of adverse effects can be increased when GW842166 is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of adverse effects can be increased when Ibipinabant is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of adverse effects can be increased when Surinabant is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of adverse effects can be increased when WIN 55212 2 is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of adverse effects can be increased when Nabiximols is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of adverse effects can be increased when Palmidrol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14737",
                        "description": "The risk or severity of adverse effects can be increased when Cannabinol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11537",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Pirlimycin is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The absorption of Levodopa can be decreased when combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "The therapeutic efficacy of Rapacuronium can be decreased when used in combination with Azathioprine"
                    },
                    {
                        "drugbank-id": "DB00301",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Flucloxacillin"
                    },
                    {
                        "drugbank-id": "DB00415",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Ampicillin"
                    },
                    {
                        "drugbank-id": "DB00417",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Phenoxymethylpenicillin"
                    },
                    {
                        "drugbank-id": "DB00485",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Dicloxacillin"
                    },
                    {
                        "drugbank-id": "DB00578",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Carbenicillin"
                    },
                    {
                        "drugbank-id": "DB00607",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Nafcillin"
                    },
                    {
                        "drugbank-id": "DB00713",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Oxacillin"
                    },
                    {
                        "drugbank-id": "DB00739",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Hetacillin"
                    },
                    {
                        "drugbank-id": "DB00895",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Benzylpenicilloyl polylysine"
                    },
                    {
                        "drugbank-id": "DB00948",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Mezlocillin"
                    },
                    {
                        "drugbank-id": "DB01000",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Cyclacillin"
                    },
                    {
                        "drugbank-id": "DB01053",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Benzylpenicillin"
                    },
                    {
                        "drugbank-id": "DB01060",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Amoxicillin"
                    },
                    {
                        "drugbank-id": "DB01061",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Azlocillin"
                    },
                    {
                        "drugbank-id": "DB01147",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Cloxacillin"
                    },
                    {
                        "drugbank-id": "DB01163",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Amdinocillin"
                    },
                    {
                        "drugbank-id": "DB01602",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Bacampicillin"
                    },
                    {
                        "drugbank-id": "DB01603",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Meticillin"
                    },
                    {
                        "drugbank-id": "DB01604",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Pivampicillin"
                    },
                    {
                        "drugbank-id": "DB01605",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Pivmecillinam"
                    },
                    {
                        "drugbank-id": "DB01607",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Ticarcillin"
                    },
                    {
                        "drugbank-id": "DB08795",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Azidocillin"
                    },
                    {
                        "drugbank-id": "DB09319",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Carindacillin"
                    },
                    {
                        "drugbank-id": "DB09320",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Procaine benzylpenicillin"
                    },
                    {
                        "drugbank-id": "DB12127",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Sultamicillin"
                    },
                    {
                        "drugbank-id": "DB12343",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Temocillin"
                    },
                    {
                        "drugbank-id": "DB13300",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Epicillin"
                    },
                    {
                        "drugbank-id": "DB13337",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Pheneticillin"
                    },
                    {
                        "drugbank-id": "DB13506",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Carfecillin"
                    },
                    {
                        "drugbank-id": "DB13660",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Propicillin"
                    },
                    {
                        "drugbank-id": "DB13686",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Clometocillin"
                    },
                    {
                        "drugbank-id": "DB13693",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Sulbenicillin"
                    },
                    {
                        "drugbank-id": "DB13739",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Penamecillin"
                    },
                    {
                        "drugbank-id": "DB13814",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Talampicillin"
                    },
                    {
                        "drugbank-id": "DB13816",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Aspoxicillin"
                    },
                    {
                        "drugbank-id": "DB13836",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Metampicillin"
                    },
                    {
                        "drugbank-id": "DB00911",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Tinidazole"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Metronidazole"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Miconazole"
                    },
                    {
                        "drugbank-id": "DB13026",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Ornidazole"
                    },
                    {
                        "drugbank-id": "DB13319",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Propenidazole"
                    },
                    {
                        "drugbank-id": "DB00455",
                        "description": "Rapacuronium may increase the anticholinergic activities of Loratadine"
                    },
                    {
                        "drugbank-id": "DB14507",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Lithium citrate"
                    },
                    {
                        "drugbank-id": "DB14506",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Lithium hydroxide"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The risk or severity of Tachycardia can be increased when Nicotine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The risk or severity of Tachycardia can be increased when Phentermine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "The risk or severity of Tachycardia can be increased when Midodrine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "The risk or severity of Tachycardia can be increased when Bethanidine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "The risk or severity of Tachycardia can be increased when Isoetharine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The risk or severity of Tachycardia can be increased when Norepinephrine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The risk or severity of Tachycardia can be increased when Phenylephrine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "The risk or severity of Tachycardia can be increased when Phenylpropanolamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The risk or severity of Tachycardia can be increased when Labetalol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "The risk or severity of Tachycardia can be increased when Metaraminol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "The risk or severity of Tachycardia can be increased when Guanabenz is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of Tachycardia can be increased when Adenosine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The risk or severity of Tachycardia can be increased when Epinephrine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "The risk or severity of Tachycardia can be increased when Methoxamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "The risk or severity of Tachycardia can be increased when Phenmetrazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "The risk or severity of Tachycardia can be increased when Dobutamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The risk or severity of Tachycardia can be increased when Pseudoephedrine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "The risk or severity of Tachycardia can be increased when Ritodrine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "The risk or severity of Tachycardia can be increased when Bitolterol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of Tachycardia can be increased when Salmeterol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of Tachycardia can be increased when Formoterol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "The risk or severity of Tachycardia can be increased when Dopamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of Tachycardia can be increased when Salbutamol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "The risk or severity of Tachycardia can be increased when Isoprenaline is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "The risk or severity of Tachycardia can be increased when Arbutamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of Tachycardia can be increased when Cilostazol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The risk or severity of Tachycardia can be increased when Lisdexamfetamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of Tachycardia can be increased when Arformoterol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "The risk or severity of Tachycardia can be increased when Pirbuterol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "The risk or severity of Tachycardia can be increased when Ephedra sinica root is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The risk or severity of Tachycardia can be increased when Ephedrine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The risk or severity of Tachycardia can be increased when Mephentermine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "The risk or severity of Tachycardia can be increased when Procaterol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "The risk or severity of Tachycardia can be increased when Clenbuterol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The risk or severity of Tachycardia can be increased when 2 5 Dimethoxy 4 ethylamphetamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The risk or severity of Tachycardia can be increased when Chlorphentermine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The risk or severity of Tachycardia can be increased when Dextroamphetamine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "The risk or severity of Tachycardia can be increased when Phendimetrazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Amibegron"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Solabegron"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Droxidopa"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Isometheptene"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Levonordefrin"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Naphazoline"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Tetryzoline"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Protokylol"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Tyramine"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Adrafinil"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Isoxsuprine"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Hexoprenaline"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Etilefrine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Olodaterol"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Cirazoline"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Synephrine"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Moxonidine"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Doxofylline"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Iofetamine I 123"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Racepinephrine"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with DL Methylephedrine"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Amitraz"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Ractopamine"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Etafedrine"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Anisodamine"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with PF 00610355"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Ritobegron"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Abediterol"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Tulobuterol"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Dopexamine"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Higenamine"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Reproterol"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Tramazoline"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Octopamine"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Fenozolone"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Norfenefrine"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Oxyfedrine"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Rimiterol"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Tretoquinol"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Prenalterol"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Xamoterol"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Mefenorex"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Medical Cannabis"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The therapeutic efficacy of Domperidone can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The therapeutic efficacy of Macimorelin can be decreased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Esketamine"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "The risk or severity of adverse effects can be increased when Carisoprodol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Baclofen"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The risk or severity of CNS depression can be increased when Rapacuronium is combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of sedation can be increased when Clonidine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The therapeutic efficacy of Rapacuronium can be decreased when used in combination with Donepezil"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The therapeutic efficacy of Hydrochlorothiazide can be increased when used in combination with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of sedation can be increased when Metoclopramide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The risk or severity of adverse effects can be increased when Rapacuronium is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of CNS depression can be increased when Tramadol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB01190",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of adverse effects can be increased when Ziprasidone is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "Rapacuronium can cause a decrease in the absorption of Magnesium resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of CNS depression can be increased when Haloperidol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "The risk or severity of adverse effects can be increased when Enflurane is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "Rapacuronium may increase the central nervous system depressant CNS depressant activities of Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB12404",
                        "description": "The risk or severity of sedation can be increased when Remimazolam is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of hypotension sedation death somnolence and respiratory depression can be increased when Rapacuronium is combined with Oliceridine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}